Lu et al. investigated the anti‐tumor effect of liposomes loaded with thymosaponin A (TAIII), a steroid saponin found in Anemarrhena asphodeloides, and modified with an anti‐CD44 antibody.[10] TAIII has potential as an anti‐tumor drug candidate, however, it's in vivo antitumor activity is limited by its hydrophobicity and low bioavailability. The gene discussed is CD44; the disease is neoplasm.